Latest news
Parkinson's-linked α-synuclein blocks protein transport in neurons, disrupting cells' waste recycling - Medical XpressMedical Xpress · Fri, 07 Aug 2026 17:00:03 GMTParkinson's drug developers are betting big on inflammation - Proactive financial newsProactive financial news · Fri, 07 Aug 2026 13:13:00 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSciAllSci · Thu, 06 Aug 2026 16:12:09 GMTBioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 13:40:09 GMTEarly Parkinson’s disease: α-Synuclein disrupts co-translational protein transport into the endoplasmic reticulum - Bioengineer.orgBioengineer.org · Thu, 06 Aug 2026 13:03:48 GMTEarly Parkinson’s Disease Shows Sex Differences in Striatal Functional Connectivity - Bioengineer.orgBioengineer.org · Thu, 06 Aug 2026 11:18:48 GMTα-Synuclein blocks endoplasmic reticulum co-translational protein translocation early in Parkinson’s disease - NatureNature · Thu, 06 Aug 2026 09:50:12 GMTBioVie reports positive Phase 2 results for Parkinson's candidate bezisterim - Proactive financial newsProactive financial news · Thu, 06 Aug 2026 09:03:00 GMT